Covishield | The Asian Age

Friday, Apr 26, 2024 | Last Update : 11:56 AM IST

Covishield Page-3

Senior officials in the Union health ministry said there is no need to panic as the government has ensured that there is no shortage of Covid-19 vaccines in the country. (PTI file photo)

COVID-19 surge: Passengers to Bengaluru will now need a negative test report

Several other states have also started imposing restrictions on movement of people

26 Mar 2021 1:51 AM

The Centre has purchased 11 million doses of Covishield vaccine for the ongoing inoculation drive. (Photo: AP)

Serum Institute applies for trials of another Covid-19 vaccine

The firm has already produced Covishield vaccine, co-developed by the University of Oxford and British-Swedish company AstraZeneca

31 Jan 2021 12:27 AM

The government must at least now do a rethink on the campaign and be true and honest with the people on its components. It must win people’s confidence by placing all the facts before them, to start with; piecemeal and ad hoc release of critical information is not the right way to do it. (Photo:AFP)

AA Edit | Put politics, profit aside; level with all on vaccine

The government and the companies should have been upfront about the products from the beginning

23 Jan 2021 12:00 AM

A nurse, right, performs rituals to a box containing COVID-19 vaccines upon its arrival at a government Hospital in Ahmedabad, India, Saturday, Jan. 16, 2021. (AP /Ajit Solanki)

AA Edit | Transparency the key to success of vaccine drive

If a vaccine is under trial and has not gone through the due process, its administration should be called clinical trial, not vaccination

18 Jan 2021 12:10 AM

Paracetamol may be used to provide symptomatic relief from post vaccination adverse reactions. (PTI/file)

Pregnant, lactating women should not be given COVID-19 vaccine now: Health ministry

The ministry has listed precautions and contraindications for COVID-19 vaccination along with a comparative factsheet for both the vaccines

15 Jan 2021 10:32 AM

The PMO statement said the vaccination programme is based on principles of priority groups to be vaccinated first. (PTI/file)

PM Modi to launch COVID-19 vaccination drive on January 16

Modi is likely to interact via video link with some healthcare workers fwho will be receiving the shots on the first day

15 Jan 2021 9:17 AM

Drugs Controller General of India Dr V G Somani along with Principal Director General of Press Information Bureau K S Dhatwalia (R) during a press conference to announce the approval of Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, in New Delhi, Sunday, Jan. 03, 2021. (PTI)

Covishield to cost Rs.200 per dose, export banned by government

The government is now in a hurry to start vaccination drive, the schedule for which will be announced soon

05 Jan 2021 7:23 AM

Bharat Biotech aims to recruit 26,000 volunteers across the country for the Phase-3 trials; it has crossed the 23,000-volunteer mark. (AFP)

Vaccine makers call approval a giant leap

SII has stockpiled around 5 crore dosages of the vaccine and aims to produce up to 10 crore per month by March next year

04 Jan 2021 11:22 AM

India has authorised the emergency use of two coronavirus vaccines developed by AstraZeneca and Oxford University and by local pharmaceutical firm Bharat Biotech, the country's drug regulator said Sunday. (Representational Image: PTI)

DCGI approves two Covid-19 vaccines for emergency use

The approval is expected to kick off one of the world's biggest vaccination drives in coming days in the country of 1.3 billion people

03 Jan 2021 11:54 AM

Bharat Biotech has submitted data from Phase 1 and 2 trials to the CDSCO and the Drugs Controller General of India (Representational Image: AFP)

Nod for vaccines amid scare over new strains of Covid-19

Subject Expert Committee of the CDSCO granted permission to Bharat Biotech in the ‘clinical trial’ mode and with ‘abundant precaution

03 Jan 2021 4:43 AM

Covishield has been recommended based on the human trial results in the the United Kingdom, the United States of America and India (Representational Image: AFP)

Covishield moves closer to approval

The recommendation on Covishield has been forwarded to the Drugs Controller General of India, which is likely to take a final call soon

02 Jan 2021 12:36 AM

3 of 3

Columns

Sunil Gatade